Works matching IS 00223417 AND DT 2020 AND VI 250


Results: 90
    1

    Issue Information.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 5, p. 1, doi. 10.1002/path.5416
    Publication type:
    Article
    2
    3
    4
    5

    The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immunooncology biomarkers in breast cancer clinical trials and daily practice.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 5, p. 667, doi. 10.1002/path.5406
    By:
    • Gonzalez-Ericsson, Paula I.;
    • Stovgaard, Elisabeth S.;
    • Sua, Luz F.;
    • Reisenbichler, Emily;
    • Kos, Zuzana;
    • Carter, Jodi M.;
    • Michiels, Stefan;
    • Le Quesne, John;
    • Nielsen, Torsten O.;
    • Lnkholm, Anne-Vibeke;
    • Fox, Stephen B.;
    • Adam, Julien;
    • Bartlett, John MS;
    • Rimm, David L.;
    • Quinn, Cecily;
    • Peeters, Dieter;
    • Dieci, Maria V.;
    • Vincent-Salomon, Anne;
    • Cree, Ian;
    • Hida, Akira I.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Molecular pathology of Lynch syndrome.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 5, p. 518, doi. 10.1002/path.5422
    By:
    • Cerretelli, Guia;
    • Ager, Ann;
    • Arends, Mark J.;
    • Frayling, Ian M.
    Publication type:
    Article
    17
    18
    19
    20
    21

    Issue Information.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 4, p. 1, doi. 10.1002/path.5428
    Publication type:
    Article
    22
    23

    Molecular pathology of Lynch syndrome.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 4, p. 518, doi. 10.1002/path.5422
    By:
    • Cerretelli, Guia;
    • Ager, Ann;
    • Arends, Mark J;
    • Frayling, Ian M
    Publication type:
    Article
    24
    25
    26
    27

    The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 4, p. 667, doi. 10.1002/path.5406
    By:
    • Gonzalez‐Ericsson, Paula I;
    • Stovgaard, Elisabeth S;
    • Sua, Luz F;
    • Reisenbichler, Emily;
    • Kos, Zuzana;
    • Carter, Jodi M;
    • Michiels, Stefan;
    • Le Quesne, John;
    • Nielsen, Torsten O;
    • Lænkholm, Anne‐Vibeke;
    • Fox, Stephen B;
    • Adam, Julien;
    • Bartlett, John MS;
    • Rimm, David L;
    • Quinn, Cecily;
    • Peeters, Dieter;
    • Dieci, Maria V;
    • Vincent‐Salomon, Anne;
    • Cree, Ian;
    • Hida, Akira I
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    List of Reviewers.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 4, p. 466, doi. 10.1002/path.5386
    Publication type:
    Article
    40
    41

    Issue Information.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 4, p. 1, doi. 10.1002/path.5293
    Publication type:
    Article
    42
    43
    44
    45

    LIGHT/TNFSF14 regulates estrogen deficiency‐induced bone loss.

    Published in:
    Journal of Pathology, 2020, v. 250, n. 4, p. 440, doi. 10.1002/path.5385
    By:
    • Brunetti, Giacomina;
    • Storlino, Giuseppina;
    • Oranger, Angela;
    • Colaianni, Graziana;
    • Faienza, Maria F;
    • Ingravallo, Giuseppe;
    • Di Comite, Mariasevera;
    • Reseland, Janne E;
    • Celi, Monica;
    • Tarantino, Umberto;
    • Passeri, Giovanni;
    • Ware, Carl F;
    • Grano, Maria;
    • Colucci, Silvia
    Publication type:
    Article
    46
    47
    48
    49
    50